SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...

FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...

There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to ...

Startup Clairity scored a green light from the FDA for the agency's first artificial intelligence tool designed to predict ...

FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...

Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

FDA announced the launch of Elsa, a generative artificial intelligence (AI) tool designed to help employees from scientific ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...

A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its ...